Orbis International's Flying Eye Hospital, the only fully accredited ophthalmic teaching hospital on a plane, has begun a two week training rotation in Arequipa where most instructors are themselves from the region.
When the Orbis Flying Eye Hospital touched down in Arequipa this week, the ophthalmologists walking up its stairs to teach were not visitors from abroad. They were Latin American specialists, most of them from Orbis partner hospitals in Lima and Trujillo, delivering a two-week training program in cataract, glaucoma, and retinal surgery to Peruvian counterparts in their own language.
The setup is unusual in two ways. Orbis runs the world's only fully accredited ophthalmic teaching hospital built into a cargo aircraft, a converted plane the nonprofit uses as a flying classroom. The other unusual element is the faculty. Orbis's Volunteer Faculty is, by the organization's own description, predominantly Latin American, drawn in significant part from the partner hospitals in Lima and Trujillo that have hosted previous Peru projects, including the 2018 Trujillo rotation in which Volunteer Faculty member Dr. Andrea Molinari trained local clinicians.
The current visit runs at the invitation of Peru's Ministry of Health and in partnership with Hospital Regional Honorio Delgado Espinoza, the public regional hospital serving Arequipa and much of southern Peru. Geographic focus stretches to rural and indigenous communities in the surrounding Andes, where access to subspecialty ophthalmology has historically been thin.
That framing matters because it is the explicit pitch Orbis has made for decades: capacity that stays in a country, taught by people who live there, rather than a flying surgical team that performs cases and flies home. The training model leans on simulation, on live surgical observation, and on case discussions that continue after the aircraft departs. Whether that pitch actually translates into durable capacity is a harder question than any press release can answer.
A two-week program is, by construction, a thin slice of intervention. The Arequipa rotation covers cataract, glaucoma, oculoplastics, and medical retina, four subspecialties that absorb most of the avoidable blindness in low-resource settings. Sustained retention of those skills depends on equipment, on referral networks, and on whether surgeons have enough case volume in their home hospitals to keep practicing what they learned. The aircraft's portability solves the access problem for two weeks. The months between visits are not part of the model.
Sponsors named in the Orbis announcement include Alcon, the eye-care device company; FedEx, which has provided flight support and logistics for decades; and OMEGA, the watchmaker. None are neutral players. Alcon sells intraocular lenses and surgical equipment that trainees may later specify, and OMEGA's philanthropy tends to be tied to brand-building in places where its watches are sold. The corporate involvement is a structural feature of the model, not an accident, and it shapes what the program prioritizes and what it leaves out.
Independent outcome data for Orbis in Peru is not published in a way that a reader can audit. Local partners, including Hospital Regional Honorio Delgado Espinoza and the Ministry of Health, are credited with inviting the program but are not quoted in the announcement. Any durable change in cataract surgical volume, glaucoma follow-up rates, or referral pathways in southern Peru over the next year would be a better measure of the visit's value than the takeoffs and landings.
The aircraft will leave Arequipa at the end of the two-week rotation. What it leaves behind is a cohort of clinicians, a refreshed partnership with one regional hospital, and a question worth tracking: whether the locally-led framing the announcement leans on is what Peruvian partners would actually say if asked.